Skip to main content

Conferences

Exciting and important news in the diabetes sphere from the biggest diabetes conferences around the world. 

Adam’s presentation at Friends for Life 2019
Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2019
Nine industry leaders share insights on better diabetes outcomes at lower costs – The diaTribe Foundation’s 4 th annual Musings Under the Moon
New partnerships with Tidepool Loop, plus two new models of virtual clinical care
The diaTribe team was on the ground at the 2019 ADA 79th Scientific Sessions to share several of the greatest highlights from the conference!
Big focus on heart health outcome trials with PIONEER 6 and CAROLINA in the spotlight; plus promising CGM data in adolescents with type 1 diabetes
First drug trial to show delay in type 1 diagnoses, heart and kidney benefits from Trulicity in type 2, huge focus on time-in-range, positive results for both Tandem’s...
Data on type 2 diabetes therapies and prevention, Medtronic MiniMed 780G trial starts, Beta Bionics Gen 3 iLet time-in-range results, and more!
CGM accuracy, meal timing, n ew partnerships in diabetes tech, vitamin D for prediabetes, and more!
A preview of the most exciting conference updates on diabetes drugs, devices, and more; stay tuned!
Over 160 children and teens living with type 1 diabetes were selected to travel to Washington D.C. for three days, meeting with politicians and lawmakers to advocate for...
Learn more about JDRF’s efforts in finding a cure for type 1 diabetes and read highlights from experts’ discussions on SGLT inhibitors in type 1 and Beyond A1C
News from Onduo's virtual diabetes clinic, Klue, SugarMate, and Diabits apps, Tidepool Loop, and more!
Insightful diabetes leaders discuss high-potential areas ranging from SGLT-2s in type 1 diabetes, personalized treatment plans, and the do-it-yourself Loop app
How we talk about diabetes matters; using empowering, non-stigmatizing words is important when speaking with and about people with diabetes
The benefits of measuring time in range, plus new care guidelines for adults with type 2 diabetes
CGM data in people without diabetes, time-in-range and A1C benefits in large hybrid closed loop study, plus trial results studying Jardiance in type 1 as well as Lilly’s...
SGLT-1/2 therapy for type 1 diabetes, hybrid closed loop systems in teens and children, and the importance of glucose control as an outcome in addition to A1C!
The most promising therapies in the pipeline, accuracy data on the FreeStyle Libre 2, and more
The diaTribe Foundation and TCOYD hosted a panel discussion at the ADA 78 th Scientific Sessions in Orlando, Florida; read about insights on how to improve diabetes care

Pages